Protein Posttranslational Modifications: Roles in Aging and Age-Related Disease

Abstract EN

Aging is characterized by the progressive decline of biochemical and physiological function in an individual.

Consequently, aging is a major risk factor for diseases like cancer, obesity, and type 2 diabetes.

The cellular and molecular mechanisms of aging are not well understood, nor is the relationship between aging and the onset of diseases.

One of the hallmarks of aging is a decrease in cellular proteome homeostasis, allowing abnormal proteins to accumulate.

This phenomenon is observed in both eukaryotes and prokaryotes, suggesting that the underlying molecular processes are evolutionarily conserved.

Similar protein aggregation occurs in the pathogenesis of diseases like Alzheimer’s and Parkinson’s.

Further, protein posttranslational modifications (PTMs), either spontaneous or physiological/pathological, are emerging as important markers of aging and aging-related diseases, though clear causality has not yet been firmly established.

This review presents an overview of the interplay of PTMs in aging-associated molecular processes in eukaryotic aging models.

Understanding PTM roles in aging could facilitate targeted therapies or interventions for age-related diseases.

In addition, the study of PTMs in prokaryotes is highlighted, revealing the potential of simple prokaryotic models to uncover complex aging-associated molecular processes in the emerging field of microbiogerontology.